All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Redhill Biopharma Ltd., of Tel Aviv, Israel, said the first patients were dosed in a phase II study with Bekinda 12 mg for diarrhea-predominant irritable bowel syndrome.
